Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

deleted due to error.

4 trades all day. Talk about watching and waiting.
Still prepared to wait.

Yet more good news.

Yes great news but until the powers that be see the bl***y obvious it won't have much effect to the sp.

With statements such as these...."There are improved outcomes for patients, with reduced morbidity rates, fewer complications and rapid recovery. Length of stay has been reduced from approximately 9-10 days per patient to just 6 days." It's a no brainer as they say. The problem is with NHS management the words No Brain appear to be a more apt statement.

Always good to see directors having faith in their company.

Ewan Phillips purchased 50,000 shares at 21.25 pence each on Nov 21 and 10,000 shares at 21.17 pence each on Nov 23, lifting his stake in the company to 977,156 shares or 1.06 pct.

I agree gm, although not big numbers it's better than seeing the directors selling. I look on the 'thisismoney' site for the director buy/sell transactions and for co's in general, directors buying by far outways those who are selling, this has been the case for the last month or so, very encouraging that they feel the current market woes are short term. Re DEMG still holding and waiting for those large deals, I imagine a steady increase in sales rather than a huge jump, unless the nhs pursestring holders see sense.
2517

The latest figures show that at present the NHS is underspend by 2 billion, so they will have to spend it playing catch up by next financial year or they will have that amount on their budget reduction. I know it's stupid but as we know thats how these organizations work. Lets hope they spend some of it on the CardioQ system.
But at a guess it will go on the pen pushers office carpets and furniture. After all their comfort must be their priority. Cynicism rules OK.

An article in the 'Circulation' yesterday states.

Blood transfusions during surgery may triple the risk of suffering a heart attack or stroke due to complications arising from lack of oxygen to key organs, scientist claimed yesterday.

The article goes on to say that more research is required to see if changing transfusion guidelines could cut risks.

The CardioQ is not mentioned, but as we know it's use for monitoring blood/fluid flow round the body gives surgeon and anesthetist a better blood/fluid reading than any other method.

It always appears strange to me that probably millions of pounds will be spent on such research when research that has already cost millions and proved to save lives and money (CardioQ) is largely ignored.

I think I will just have to stop banging my head against the wall of frustration, and keep taking the patience pills.

Can't take credit for finding this as it is from another site.
The info is as up to date as possible and a great way of keeping up to date with developments re the CardioQ, as it's a pris of such developments.

www.reducinglengthofstay.org.

Hopefully this will get things moving at a fast pace.
If not I have the ideal Xmas gift for all NHS trust members.
A big box of suppositories as these might be the only thing to get them to move quickly.

Director Buys ( Late Nov07)
Frankly, for a Director to buy 10k's worth is laughable - I wonder if we will see some odd RNS slipped out with bad news?

This SP has returned to start-of-year values.. . . . . and I thought it was on the "up"
Wrong again!

Deltex Medical (DEMG-AIM) S.P. 23.25p.
Our share club has held a position with DEMG for some time now, on which we are showing a 5% profit.

. The Group's principal product is the CardioQ
which is used on patients undergoing surgery and on critically ill
patients to monitor the heart's performance. This provides disposable
ultra-sound probes inserted into the esophagus to determine the amount
of blood being pumped around the bodies circulating blood volume. The
CardioQ incorporates proprietary software and a small diameter,
minimally invasive, disposable esophageal probe that is used for
transmitting and receiving an ultra-sound signal. The Group operates in
the United Kingdom and the United States of America.

Why not follow the CardioQ story at our club website www.shareclubuk.co.uk. To find out more about .Deltex just click onto www.deltexmedical.com/.

Deltex Medical (DEMG-AIM) S.P. 23.25p. Market Cap 20.12m
Our share club has held a position with DEMG for some time now, on which we are showing a profit. Of 1.25%.

The main reason why we have invested in DEMG is the proven fact that the company lead product CardioQ is the number one product of its type in medical world, also that the company is opening up the U.S. market as CardioQ has been approved by the U.S. medical insurance board for insurance cover payments for patient, therefore opening up the market for DEMG.

Why not follow the CardioQ story at our club website www.shareclubuk.co.uk. To find out more about .Deltex just click onto www.deltexmedical.com/.

Yet another positive in the HSJ.
2517

Yes, yet another glowing report re the CardioQ. This time in The Health Service Journal (HSJ).
The article also states that the HSJ is widely read amongst NHS managers and the publication of Dr Webb's article shows the growing profile of our products in delivering solutions to the challenges facing modern NHS hospitals.

But I wonder if this cloth eared, wool for brains lot, who are not worth paying in sick bags can bl**dy well read.

They make me sicker than most NHS patients are on release.

Added a few more today @ this very low level, it's been a while since they were this price. Good luck all.
2517

I wonder how the NHS Technology Adoption Hub review is going, they have had 3 complete months now, maybe some feedback is due from them.
2517

Right on cue. Looks to be doing very well in all aspects, the only blip is SupraQ sales. Latin America becoming increasingly aware of DEMG's products.
2517

Significant progress in all of its key markets.
Anticipate that sales for the year will be in excess of 4.1 million.

Nice increase from 3,511,000 previous year. Outlook is looking very good, although
we are still it appears looking for that big breakthrough.
Be interesting to see if costs per item have decreased, as presumably with increase production they will have.
Still more patience needed, but a good pre close statement.
Looking forward to full results.

Deltex Medical (DEMG-AIM) S.P. 19.00p. Market Cap 20.12m
Our share club has held a position with DEMG for some time now, on which we are showing a profit. Of 1.15%. Hot news just in from DEMG

Positive scientific review of CardioQ technology published

Pre-close update on the year ended 31 December 2007

To find out more about .DEMG click onto www.deltexmedical.com/.

myway, previously you said (post 510) that at 23.25p you had a profit of 1.25% so you must have bought at 22.96p

Now you say that at 19.00p you have a profit of 1.15% so you must have bought at 18.78p

It is good to be in profit. I am hoping for a 400% profit at least.

Nice to see 3 directors buying, 70k in total.
2517